<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111613</identifier>
<setSpec>1139-9287</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Dopamine partial agonism in antipsychoticinduced sexual dysfunction</dc:title>
<dc:description xml:lang="en">Introduction. Sexual dysfunction is a frequent side effect associated with antipsychotic treatment. It is known to be caused by the hyperprolactinemia that results from the D2 receptor blockade that is characteristic of antipsychotic drugs. The D2 partial dopaminergic agonism of aripiprazole could explain why its use does not usually cause this side effect, and may even revert it when added to another antipsychotic. Case reports. We present the cases of two patients treated with D2 dopaminergic antagonists for a first episode of psychosis, who complained of amenorrhea and erectile dysfunction during follow-up. After the addition of aripiprazole to their previous antipsychotic treatment, these side effects reverted without a negative impact on treatment adherence or therapeutic efficacy. Conclusions. Pharmacological treatments with the potential of reverting sexual dysfunction secondary to antipsychotic treatment can improve compliance and quality of life of our patients, especially in those who are younger and are being treated for a first psychotic episode. In the cases reported here, the use of aripiprazole as an adjunctive treatment resulted in the disappearance of the undesirable effects without affecting the efficacy already achieved with the previous antipsychotic treatment (AU)</dc:description>
<dc:creator>Bagney, Alexandra</dc:creator>
<dc:creator>Oliva, Jose de la</dc:creator>
<dc:creator>Jimenez-Arriero, Miguel A</dc:creator>
<dc:creator>Rodriguez-Jimenez, Roberto</dc:creator>
<dc:creator>Mesa, Natalia</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La disfunción sexual es un efecto secundario frecuente de los antipsicóticos. Ha sido relacionada con la hiperprolactinemia producida por el antagonismo dopaminérgico D2 propio de los fármacos antipsicóticos. El agonismo parcial dopaminérgico D2 del aripiprazol podría explicar por qué su utilización no suele producir ese efecto secundario y que incluso lo revierta al añadirse aripiprazol al tratamiento con otros antipsicóticos. Casos clínicos. Se presentan dos casos clínicos con un primer episodio psicótico en tratamiento con antagonistas dopaminérgicos D2, que desarrollan amenorrea y disfunción eréctil respectivamente. Tras añadir aripiprazol a su tratamiento antipsicótico previo remiten estos efectos secundarios manteniendo adherencia y eficacia terapéutica. Conclusiones. Los fármacos que pueden disminuir los efectos secundarios en la esfera sexual pueden mejorar la aceptación al tratamiento y la calidad de vida, especialmente en pacientes jóvenes con primeros episodios psicóticos. En los casos presentados, el uso de aripiprazol como fármaco adyuvante, se tradujo en una mejoría en los efectos secundarios de la esfera sexual, sin comprometer la eficacia terapéutica (AU)</dc:description>
<dc:source>Actas Esp Psiquiatr;41(2): 130-132, mar.-abr. 2013.</dc:source>
<dc:identifier>ibc-111613</dc:identifier>
<dc:title xml:lang="es">Agonismo parcial dopaminérgico en la disfunción sexual secundaria a antipsicóticos</dc:title>
<dc:subject>^d14542^s22020</dc:subject>
<dc:subject>^d33534^s22012</dc:subject>
<dc:subject>^d33534^s22056</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d33534^s22057</dc:subject>
<dc:subject>^d33534^s22036</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d52908</dc:subject>
<dc:subject>^d33534^s22032</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d32276</dc:subject>
<dc:subject>^d14542^s22000</dc:subject>
<dc:subject>^d23620^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201304</dc:date>
</metadata>
</record>
</ibecs-document>
